Fitlife Brands (FTLF) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $8.58, -1.04% vs the prior close of $8.67.
- Volume 25.90K shares, 2.2x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
FTLF dips 1.0% to $8.58, a 52-week low on 2.2x normal volume. Closed at $8.58, -1.04% vs the prior close of $8.67. Day range $8.52–$8.84, opened at $8.69.
FTLF daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — FTLF dips 1.0% to $8.58, a 52-week low on 2.2x normal volume
- Closed at $8.58, -1.04% vs the prior close of $8.67. Day range $8.52–$8.84, opened at $8.69.
- Volume was 25.90K shares, 2.2x its 50-day average of 11.90K — unusually heavy trading.
- Price is -10.6% vs its 50-day average ($9.59) and -25.9% vs its 200-day average ($11.58).
- 52-week range $8.50–$20.07; today's close sits at 1% of that range, 57.2% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — FTLF slides 4.4% to $8.67, a 52-week low
- Closed at $8.67, -4.41% vs the prior close of $9.07. Day range $8.61–$9.11, opened at $8.85.
- Volume was 18.90K shares, 1.6x its 50-day average of 11.68K.
- Price is -9.9% vs its 50-day average ($9.63) and -25.4% vs its 200-day average ($11.62).
- 52-week range $8.50–$20.15; today's close sits at 1% of that range, 57.0% below the 52-week high.
Oct 13, 2026 — FTLF dips 1.7% to $9.07
- Closed at $9.07, -1.73% vs the prior close of $9.23. Day range $8.69–$9.32, opened at $9.30.
- Volume was 12.70K shares, 1.1x its 50-day average of 11.55K.
- Price is -6.0% vs its 50-day average ($9.65) and -22.2% vs its 200-day average ($11.65).
- 52-week range $8.50–$20.80; today's close sits at 5% of that range, 56.4% below the 52-week high.
Oct 12, 2026 — FTLF ends flat (+0.2%) to $9.23 on 2.0x normal volume
- Closed at $9.23, +0.22% vs the prior close of $9.21. Day range $9.15–$9.81, opened at $9.39.
- Volume was 22.50K shares, 2.0x its 50-day average of 11.23K — unusually heavy trading.
- Price is -4.5% vs its 50-day average ($9.67) and -21.0% vs its 200-day average ($11.69).
- 52-week range $8.50–$20.80; today's close sits at 6% of that range, 55.6% below the 52-week high.
Oct 9, 2026 — FTLF jumps 5.9% to $9.21
- Closed at $9.21, +5.86% vs the prior close of $8.70. Day range $8.57–$9.22, opened at $8.66.
- Volume was 14.50K shares, 1.3x its 50-day average of 11.21K.
- Price is -4.9% vs its 50-day average ($9.68) and -21.4% vs its 200-day average ($11.72).
- 52-week range $8.50–$20.98; today's close sits at 6% of that range, 56.1% below the 52-week high.
Oct 8, 2026 — FTLF slides 5.7% to $8.70, a 52-week low on 2.1x normal volume
- Closed at $8.70, -5.74% vs the prior close of $9.23. Day range $8.50–$9.14, opened at $9.05.
- Volume was 23.40K shares, 2.1x its 50-day average of 10.98K — unusually heavy trading.
- Price is -10.3% vs its 50-day average ($9.69) and -26.0% vs its 200-day average ($11.76).
- 52-week range $8.50–$20.98; today's close sits at 2% of that range, 58.5% below the 52-week high.
Oct 7, 2026 — FTLF rises 2.3% to $9.23
- Closed at $9.23, +2.33% vs the prior close of $9.02. Day range $9.00–$9.43, opened at $9.06.
- Volume was 16.40K shares, 1.5x its 50-day average of 11.05K.
- Price is -5.1% vs its 50-day average ($9.73) and -21.8% vs its 200-day average ($11.80).
- 52-week range $8.67–$20.98; today's close sits at 5% of that range, 56.0% below the 52-week high.
Oct 6, 2026 — FTLF dips 0.4% to $9.02, a 3-month low, 4 down days in a row
- Closed at $9.02, -0.44% vs the prior close of $9.06. Day range $9.02–$9.30, opened at $9.30.
- Volume was 4.30K shares, 0.4x its 50-day average of 11.66K — lighter than usual.
- Price is -7.4% vs its 50-day average ($9.74) and -23.9% vs its 200-day average ($11.85).
- 52-week range $8.67–$20.98; today's close sits at 3% of that range, 57.0% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — FTLF dips 1.7% to $9.06, a 3-month low, 3 down days in a row
- Closed at $9.06, -1.74% vs the prior close of $9.22. Day range $9.00–$9.33, opened at $9.11.
- Volume was 9.10K shares, 0.8x its 50-day average of 11.71K.
- Price is -7.1% vs its 50-day average ($9.75) and -23.8% vs its 200-day average ($11.89).
- 52-week range $8.67–$20.98; today's close sits at 3% of that range, 56.8% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — FTLF dips 0.6% to $9.22
- Closed at $9.22, -0.65% vs the prior close of $9.28. Day range $9.13–$9.22, opened at $9.20.
- Volume was 2.10K shares, 0.2x its 50-day average of 12.11K — lighter than usual.
- Price is -5.7% vs its 50-day average ($9.78) and -22.7% vs its 200-day average ($11.93).
- 52-week range $8.67–$20.98; today's close sits at 4% of that range, 56.1% below the 52-week high.
FTLF latest news & SEC filings
Every SEC filing by or about FTLF in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Pappas Shannon K. bought 1,000 shares at $10.25 (≈$10.25K) on Aug 19, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 5.07 — Reported shareholder vote results.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $1.95M (prior year $1.75M) (+11.6% vs Jun 30, 2025)
- Diluted EPS: $0.20 (prior year $0.18) (+11.1% vs Jun 30, 2025)
Aug 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 26, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jun 26, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jun 26, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade FTLF
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Apr 1, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.72% (largest 5.9%).
- Liquidity: about 12.66K shares (≈$108.62K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $8.58 vs a range of $8.50–$20.07 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 2:1 on Feb 7, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 7 open-market buys, 0 sales; latest: Shannon K. Pappas bought 1,000 shares on Aug 19, 2026.
- Latest filings: 8-K Sep 9, 2026; 8-K Aug 13, 2026; 10-Q Aug 13, 2026.
- Share count: 9.39M shares outstanding (Aug 12, 2026), +0.0% vs a year earlier.
- Listing: Nasdaq · industry: Medicinal Chemicals & Botanical Products.
FTLF market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 8.69 | 8.84 | 8.52 | 8.58 | 25.90K |
| Oct 14, 2026 | 8.85 | 9.11 | 8.61 | 8.67 | 18.90K |
| Oct 13, 2026 | 9.30 | 9.32 | 8.69 | 9.07 | 12.70K |
| Oct 12, 2026 | 9.39 | 9.81 | 9.15 | 9.23 | 22.50K |
| Oct 9, 2026 | 8.66 | 9.22 | 8.57 | 9.21 | 14.50K |
| Oct 8, 2026 | 9.05 | 9.14 | 8.50 | 8.70 | 23.40K |
| Oct 7, 2026 | 9.06 | 9.43 | 9.00 | 9.23 | 16.40K |
| Oct 6, 2026 | 9.30 | 9.30 | 9.02 | 9.02 | 4.30K |
| Oct 5, 2026 | 9.11 | 9.33 | 9.00 | 9.06 | 9.10K |
| Oct 2, 2026 | 9.20 | 9.22 | 9.13 | 9.22 | 2.10K |
| Oct 1, 2026 | 9.30 | 9.30 | 9.02 | 9.28 | 19.00K |
| Sep 30, 2026 | 9.13 | 9.32 | 9.13 | 9.30 | 3.60K |
| Sep 29, 2026 | 9.29 | 9.31 | 9.02 | 9.09 | 4.70K |
| Sep 28, 2026 | 9.30 | 9.36 | 9.13 | 9.29 | 8.40K |
| Sep 25, 2026 | 9.17 | 9.32 | 9.17 | 9.26 | 2.90K |
| Sep 24, 2026 | 9.35 | 9.43 | 9.09 | 9.28 | 11.20K |
| Sep 23, 2026 | 9.40 | 9.42 | 9.28 | 9.39 | 7.70K |
| Sep 22, 2026 | 9.25 | 9.36 | 9.25 | 9.31 | 7.10K |
| Sep 21, 2026 | 9.26 | 9.51 | 9.07 | 9.28 | 17.60K |
| Sep 18, 2026 | 9.42 | 9.60 | 9.25 | 9.32 | 21.20K |
About Fitlife Brands
Fitlife Brands (FTLF) is listed on the Nasdaq and classified by the SEC under “Medicinal Chemicals & Botanical Products”. Its business address is in OMAHA, NE. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1374328.
FTLF board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Grant Robert Dawson | Director | Apr 14, 2026 |
| Matthew Lingenbrink | Director | Apr 14, 2026 |
| Shannon K. Pappas | Director | Aug 21, 2026 |
| Seth Yakatan | Director | Apr 20, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ryan P. Hansen | President | May 19, 2026 |
| Jakob York | CHIEF FINANCIAL OFFICER | Sep 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 19, 2026 | Shannon K. Pappas | Buy | 1,000 | $10.25 |
| Apr 10, 2026 | Grant Robert Dawson | Buy | 3,000 | $9.98 |
| Apr 10, 2026 | Matthew Lingenbrink | Buy | 3,000 | $9.76 |
| Jan 15, 2026 | Seth Yakatan | Buy | 164 | $15.36 |
| Dec 15, 2025 | Seth Yakatan | Buy | 139 | $18.31 |
| Sep 15, 2025 | Seth Yakatan | Buy | 142 | $17.87 |
| Aug 25, 2025 | Seth Yakatan | Buy | 148 | $17.00 |
FTLF financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $6.33M | 0.63 | $7.44M |
| Dec 31, 2024 | — | $8.98M | 0.91 | $9.61M |
| Dec 31, 2023 | — | $5.30M | 0.54 | $4.22M |
| Dec 31, 2022 | — | $4.43M | 0.89 | $4.13M |
| Dec 31, 2021 | — | $5.41M | 1.13 | $4.48M |
Latest balance sheet: total assets $102.59M, total liabilities $55.22M, cash $8.43M (as of Jun 30, 2026).
FTLF earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $11.19 |
| May 14, 2026 | 8-K Item 2.02 (results) | $10.24 |
| Apr 1, 2026 | 8-K Item 2.02 (results) | $12.10 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $18.45 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $16.15 |
| May 15, 2025 | 8-K Item 2.02 (results) | $14.46 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $12.97 |
| Mar 13, 2025 | 8-K Item 2.02 (results) | $13.84 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $16.54 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Medicinal Chemicals & Botanical Products
Definium Therapeutics (DFTX)Regencell Bioscience (RGC)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)Aurora Cannabis (ACB)Glass House Brands (GLAS)Usana Health Sciences (USNA)Cronos (CRON)Canopy Growth (CGC)Sndl (SNDL)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on FTLF
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.